Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) Bristol Myers Squibb CO Transaction History
Fjarde Ap Fonden (The Fourth Swedish National Pensionfund)
- $8.86 Billion
- Q2 2024
A detailed history of Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fjarde Ap Fonden (The Fourth Swedish National Pensionfund) holds 474,006 shares of BMY stock, worth $25.5 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
474,006Holding current value
$25.5 Million% of portfolio
0.22%Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,741Shares Held
1.57BCall Options Held
28.2MPut Options Held
29.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.55 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.18 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.13 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.25 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...